7 Recruiting HIV Infections Phase 2 Clinical Trials
Active phase 2 studies for hiv infections enrolling across the USA. Verify eligibility and contact site coordinators.
All HIV Infections studiesPhase 2 Studies for HIV Infections
🔵 Active, Not Recruiting Phase2
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)
📍 GSK Investigational Site — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
📍 GSK Investigational Site — Birmingham, Alabama
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2
Precision Microbiota Interventions for Senoreduction Trial
📍 LSU Health — New Orleans, Louisiana
View Study & Checklist ➔ 🟢 Recruiting Phase2
Imaging Immune Activation in HIV by PET-MR
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
📍 GSK Investigational Site — Bakersfield, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
CAR-T Cells for HIV Infection
📍 University of California, Davis — Sacramento, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
📍 GSK Investigational Site — Long Beach, California
View Study & Checklist ➔